Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.95
0 %
$ 518 M
Market Cap
-6.5
P/E
BALANCE SHEET
1.47 B
ASSETS
244 M
LIABILITIES
1.21 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
SNDL Inc.
| Current Assets | 407 M |
| Cash & Short-Term Investments | 202 M |
| Receivables | 27.1 M |
| Other Current Assets | 178 M |
| Non-Current Assets | 1.07 B |
| Long-Term Investments | 568 M |
| PP&E | 283 M |
| Other Non-Current Assets | 216 M |
| Current Liabilities | 103 M |
| Accounts Payable | 22 M |
| Short-Term Debt | 30.5 M |
| Other Current Liabilities | 50.6 M |
| Non-Current Liabilities | 141 M |
| Long-Term Debt | 136 M |
| Other Non-Current Liabilities | 4.18 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Feb-2018 | Feb-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 195.0 | 279.6 | 558.3 | 60.4 | 45.3 | 7.7 | 3.7 |
| Short Term Investments | 6.6 | 32.2 | 90.8 | 0 | 0 | 0 | 0 |
| Receivables | 27.1 | 22.6 | 10.9 | 15.9 | 27.6 | 0.3 | 81.6 K |
| Inventory | 129.5 | 131.3 | 33.9 | 29.1 | 74.3 | 0.4 | 0 |
| Other Current Assets | 48.7 | 35.8 | 34.4 | 13.0 | 25.4 | 0.6 | 0.6 |
| Total Current Assets | 406.9 | 501.5 | 728.2 | 118.4 | 172.6 | 8.9 | 4.2 |
| PP&E | 282.6 | 277.6 | 63.2 | 119.6 | 282.0 | 16.3 | 8.0 |
| Intangible Assets | 73.1 | 74.9 | 4.7 | 5.1 | 44.0 | 0.5 | 0.5 |
| Goodwill | 119.3 | 67.3 | 114.5 | 0 | 11.4 | 0 | 0 |
| Long Term Investments | 568.0 | 629.6 | 505.9 | 51.9 | 0 | 0 | 0 |
| Other Long Term Assets | 23.2 | 8.6 | 7.7 | (173.9) | (337.4) | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 473.2 | 1 559.3 | 1 424.3 | 294.9 | 510.0 | 25.8 | 12.7 |
| LIABILITIES | |||||||
| Accounts Payable | 22.0 | 9.8 | 4.2 | 4.8 | 20.2 | 0 | 0 |
| Short Term Debt | 30.5 | 30.2 | 5.7 | 0.4 | 178.6 | 7.0 | 7.0 |
| Other Current Liabilities | 50.6 | 49.4 | (4.2) | 18.9 | 70.4 | 4.9 | (5.9) |
| Total Current Liabilities | 103.1 | 89.4 | 65.9 | 24.1 | 269.2 | 11.9 | 1.1 |
| Long Term Debt | 136.5 | 139.6 | 27.8 | 1.0 | 32.5 | 0.1 | 0.1 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 3.4 | 0 | 0 |
| Other Liabilities | 4.2 | 2.7 | 4.5 | 0 | (16.2) | 0 | 99.2 K |
| Total Liabilities | 243.8 | 231.7 | 98.1 | 25.2 | 288.8 | 12.0 | 1.1 |
| EQUITY | |||||||
| Common Stock | 2 375.9 | 2 292.8 | 2 035.7 | 762.0 | 509.7 | 25.8 | 15.1 |
| Retained Earnings | (1 260.9) | (1 092.0) | (788.5) | (564.6) | (360.3) | (16.6) | (3.6) |
| Other Accumulative Comprehensive Income/Loss | 19.4 | 32.2 | 7.6 | 8.4 | 6.9 | (0.5) | (0.1) |
| Total Equity | 1 229.3 | 1 327.7 | 1 326.1 | 269.7 | 221.2 | 13.7 | 0 |
| Total Liabilities and Equity | 1 473.2 | 1 559.3 | 1 424.3 | 294.9 | 510.0 | 25.8 | 12.7 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 259.4 | 229.9 | 186.0 | 21.9 | 8.6 | 8.4 | 8.4 |